$2.30+0.03 (+1.32%)
Healthcare Triangle, Inc., a healthcare information technology company, focuses on developing solutions in the sectors of cloud services, data science, and professional and managed services for the electronic health record, and healthcare and life sciences industry.
Healthcare Triangle, Inc. in the Healthcare sector is trading at $2.30. The stock is currently near its 52-week low of $2.06, remaining 98.0% below its 200-day moving average. Technical signals show neutral RSI of 38 and bullish MACD crossover, explaining why HCTI maintains its current current market pressure. The Whystock Score of 25/100 signals elevated caution as indicators diverge.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Healthcare Triangle, Inc., a healthcare information technology company, focuses on developing solutions in the sectors of cloud services, data science, and professional and managed services for the electronic health record, and healthcare and life sc...
US stocks looked set to open little changed Thursday as investors digested major earnings reports a
Healthcare Triangle (HCTI) announced that it will effect a 1-for-60 reverse stock split of its common stock. The reverse stock split will become effective at 12:01 a.m. Eastern Time on Tuesday, February 10, 2026, and the company’s common stock will commence trading on the Nasdaq Capital Market on a post-split basis at the opening of the market on February 10, 2026, pending confirmation by the Depository Trust Company and the Nasdaq. The company’s common stock will continue to trade on the Nasdaq
Kosmos Energy Ltd. 24,086,956 1.72
Healthcare Triangle (HCTI) has signed a non-binding Letter of Intent, or LOI, to acquire the assets of Teyame.AI, a Spain-based company dealing in AI-powered omnichannel customer experience solutions. By combining HCTI’s healthcare technology expertise with Teyame’s AI automation customer engagement platform, an integrated ecosystem would be created where every patient touchpoint would become intelligent, personalized, and outcome-focused. The company expects Teyame to generate approximately $34